Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Firas Aljabery

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
BJU International|September 26, 2018
Modulation of the inflammatory response after sclerotherapy for hydrocoele/spermatocoeleStaffan Jahnson, Johan Rosell, Firas Aljabery
BJU International|May 24, 2021
Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancerStaffan Jahnson, Peter Söderkvist, Firas Aljabery, et al.
BJU International|July 6, 2023
Bladder cancer grading using the four-tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classificationsStaffan Jahnson, Georg Jancke, Hans Olsson, et al.
Scandinavian Journal of Urology|November 10, 2020
Stapled versus robot-sewn ileo-ileal anastomosis during robot-assisted radical cystectomy: a review of outcomes in urinary bladder cancer patientsFiras Aljabery, Georg Jancke, Per Skoglund, et al.
Urologic Oncology|December 31, 2017
M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancerFiras Aljabery, Hans Olsson, Oliver Gimm, et al.
BJU International|November 1, 2016
Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer: a prospective clinical studyFiras Aljabery, Ivan Shabo, Hans Olsson, et al.
Urologic Oncology|December 13, 2018
The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancerFiras Aljabery, Ivan Shabo, Oliver Gimm, et al.
International Urology and Nephrology|November 21, 2019
The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluationKristoffer Ottosson, Sofia Pelander, Markus Johansson, et al.
Urologic Oncology|January 26, 2023
The emerging role of cell cycle protein p53 expression by tumor cells and M2-macrophage infiltration in urinary bladder cancerFiras Aljabery, Ivan Shabo, Aus Saudi, et al.
Scandinavian Journal of Urology|September 21, 2022
Community-onset urosepsis: incidence and risk factors for 30-day mortality - a retrospective cohort studyMartin Holmbom, Maria Andersson, Magnus Grabe, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
BJU International|September 26, 2018
Modulation of the inflammatory response after sclerotherapy for hydrocoele/spermatocoeleStaffan Jahnson, Johan Rosell, Firas Aljabery
BJU International|May 24, 2021
Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancerStaffan Jahnson, Peter Söderkvist, Firas Aljabery, et al.
BJU International|July 6, 2023
Bladder cancer grading using the four-tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classificationsStaffan Jahnson, Georg Jancke, Hans Olsson, et al.
Scandinavian Journal of Urology|November 10, 2020
Stapled versus robot-sewn ileo-ileal anastomosis during robot-assisted radical cystectomy: a review of outcomes in urinary bladder cancer patientsFiras Aljabery, Georg Jancke, Per Skoglund, et al.
Urologic Oncology|December 31, 2017
M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancerFiras Aljabery, Hans Olsson, Oliver Gimm, et al.
BJU International|November 1, 2016
Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer: a prospective clinical studyFiras Aljabery, Ivan Shabo, Hans Olsson, et al.
Urologic Oncology|December 13, 2018
The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancerFiras Aljabery, Ivan Shabo, Oliver Gimm, et al.
International Urology and Nephrology|November 21, 2019
The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluationKristoffer Ottosson, Sofia Pelander, Markus Johansson, et al.
Urologic Oncology|January 26, 2023
The emerging role of cell cycle protein p53 expression by tumor cells and M2-macrophage infiltration in urinary bladder cancerFiras Aljabery, Ivan Shabo, Aus Saudi, et al.
Scandinavian Journal of Urology|September 21, 2022
Community-onset urosepsis: incidence and risk factors for 30-day mortality - a retrospective cohort studyMartin Holmbom, Maria Andersson, Magnus Grabe, et al.
Pageof 6